Prescription drug · ANDA
erythromycin NDC 68071-4791
Erythromycin 20 mg/mL · Solution · Topical · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-4791-6 | 68071479106 | 60 mL in 1 BOTTLE (68071-4791-6)Marketed from Mar 4, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- erythromycin
- Generic name (nonproprietary)
- erythromycin
- Active ingredients
- Erythromycin — 20 mg/mL
- Dosage form
- Solution
- Route
- Topical
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 063038
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
- Identifiers
- Product ID 68071-4791_1adc3829-e999-21e1-e063-6294a90a7632SPL ID 1adc3829-e999-21e1-e063-6294a90a7632SPL set ID 8349b4ec-3ca6-bdb6-e053-2a91aa0a8b63RxCUI 318202UNII 63937KV33DUPC 0368071479164
- Pharmacologic class
- Macrolide Antimicrobial; Macrolide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071479106followed by a unit qualifier and the quantityPackage 68071-4791-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Erythromycin Topical Solution USP, 2% is indicated for the topical treatment of acne vulgaris.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 063038
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| erythromycin | Erythromycin 20 mg/mL | SolutionTopical | Padagis Israel Pharmaceuticals Ltd | 45802-038 |
| erythromycin | Erythromycin 20 mg/mL | SolutionTopical | Bryant Ranch Prepack | 72162-2075 |